Virus de la fièvre hémorragique de Crimée-Congo : Questions médicales fréquentes
Nom anglais: Hemorrhagic Fever Virus, Crimean-Congo
Descriptor UI:D003225
Tree Number:B04.820.480.750.565.400
Termes MeSH sélectionnés :
Program Evaluation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus de la fièvre hémorragique de Crimée-Congo : Questions médicales les plus fréquentes",
"headline": "Virus de la fièvre hémorragique de Crimée-Congo : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus de la fièvre hémorragique de Crimée-Congo : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus de la fièvre hémorragique de Crimée-Congo"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Nairovirus",
"url": "https://questionsmedicales.fr/mesh/D016855",
"about": {
"@type": "MedicalCondition",
"name": "Nairovirus",
"code": {
"@type": "MedicalCode",
"code": "D016855",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.750.565"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus de la fièvre hémorragique de Crimée-Congo",
"alternateName": "Hemorrhagic Fever Virus, Crimean-Congo",
"code": {
"@type": "MedicalCode",
"code": "D003225",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Masayuki Saijo",
"url": "https://questionsmedicales.fr/author/Masayuki%20Saijo",
"affiliation": {
"@type": "Organization",
"name": "Sapporo City Public Health Office."
}
},
{
"@type": "Person",
"name": "Fei Deng",
"url": "https://questionsmedicales.fr/author/Fei%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Virology and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071/430207, China. df@wh.iov.cn."
}
},
{
"@type": "Person",
"name": "David W Hawman",
"url": "https://questionsmedicales.fr/author/David%20W%20Hawman",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, United States."
}
},
{
"@type": "Person",
"name": "Heinz Feldmann",
"url": "https://questionsmedicales.fr/author/Heinz%20Feldmann",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Virology, Division of Intramural Research, NIAID, NIH, Hamilton, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An evaluation of the aged mental health and primary care partnership program.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36444132",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10398562221141337"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of a tailored epilepsy training program for healthcare providers in Uganda.",
"datePublished": "2022-11-26",
"url": "https://questionsmedicales.fr/article/36446268",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.yebeh.2022.108977"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Scoping Review of Health Care Faculty Mentorship Programs in Academia: Implications for Program Design, Implementation, and Outcome Evaluation.",
"datePublished": "2022-10-05",
"url": "https://questionsmedicales.fr/article/36215162",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CEH.0000000000000459"
}
},
{
"@type": "ScholarlyArticle",
"name": "Delivering COVID-19 Vaccine via Trusted Social Services: Program Evaluation Results from the Chicagoland CEAL Program.",
"datePublished": "2023-07-12",
"url": "https://questionsmedicales.fr/article/37438456",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10900-023-01242-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "From the Brazilian Income Transfer Program to Brazil Assistance: challenges and achievements according to a theory-driven evaluation research on the program.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37466556",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0102-311XPT207922"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN de polarité négative",
"item": "https://questionsmedicales.fr/mesh/D000086103"
},
{
"@type": "ListItem",
"position": 5,
"name": "Bunyaviridae",
"item": "https://questionsmedicales.fr/mesh/D002043"
},
{
"@type": "ListItem",
"position": 6,
"name": "Nairovirus",
"item": "https://questionsmedicales.fr/mesh/D016855"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus de la fièvre hémorragique de Crimée-Congo",
"item": "https://questionsmedicales.fr/mesh/D003225"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus de la fièvre hémorragique de Crimée-Congo - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Comment diagnostique-t-on l'infection par le virus CCHF ?\nQuels tests sont utilisés pour confirmer une infection CCHF ?\nQuand doit-on suspecter une infection par CCHF ?\nLes tests de laboratoire sont-ils fiables pour CCHF ?\nPeut-on diagnostiquer CCHF par des symptômes cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D003225?mesh_terms=Program+Evaluation&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Quels sont les symptômes initiaux de CCHF ?\nY a-t-il des symptômes hémorragiques dans CCHF ?\nLes symptômes de CCHF peuvent-ils évoluer rapidement ?\nQuels signes indiquent une forme sévère de CCHF ?\nLes symptômes de CCHF sont-ils similaires à d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D003225?mesh_terms=Program+Evaluation&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Comment prévenir l'infection par CCHF ?\nLes vaccins existent-ils pour CCHF ?\nQuelles mesures de contrôle des tiques sont efficaces ?\nLes animaux domestiques peuvent-ils transmettre CCHF ?\nQuelles précautions pour les travailleurs de la santé ?",
"url": "https://questionsmedicales.fr/mesh/D003225?mesh_terms=Program+Evaluation&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Quel est le traitement principal pour CCHF ?\nLes antibiotiques sont-ils efficaces contre CCHF ?\nComment gérer les cas sévères de CCHF ?\nY a-t-il des traitements expérimentaux pour CCHF ?\nLe repos est-il recommandé pour les patients atteints de CCHF ?",
"url": "https://questionsmedicales.fr/mesh/D003225?mesh_terms=Program+Evaluation&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Quelles sont les complications possibles de CCHF ?\nCCHF peut-elle entraîner des séquelles ?\nQuel est le taux de mortalité associé à CCHF ?\nLes complications surviennent-elles rapidement ?\nComment les complications de CCHF sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D003225?mesh_terms=Program+Evaluation&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus de la fièvre hémorragique de Crimée-Congo",
"description": "Qui est le plus à risque de contracter CCHF ?\nLes voyageurs dans certaines régions sont-ils à risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLes agriculteurs sont-ils exposés à CCHF ?\nLes personnes en contact avec des sangs d'animaux sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D003225?mesh_terms=Program+Evaluation&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'infection par le virus CCHF ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer une infection CCHF ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et la PCR en temps réel sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand doit-on suspecter une infection par CCHF ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de fièvre, hémorragies et exposition à des tiques ou à des animaux infectés."
}
},
{
"@type": "Question",
"name": "Les tests de laboratoire sont-ils fiables pour CCHF ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests de laboratoire sont fiables, surtout lorsqu'ils sont effectués tôt."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer CCHF par des symptômes cliniques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes cliniques sont non spécifiques; des tests sont nécessaires pour confirmation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes initiaux de CCHF ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires, et maux de tête sont les premiers symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes hémorragiques dans CCHF ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements peuvent survenir, notamment des saignements de nez et des gencives."
}
},
{
"@type": "Question",
"name": "Les symptômes de CCHF peuvent-ils évoluer rapidement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent s'aggraver rapidement, menant à des complications graves."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une forme sévère de CCHF ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de choc, des hémorragies massives et une défaillance organique sont préoccupants."
}
},
{
"@type": "Question",
"name": "Les symptômes de CCHF sont-ils similaires à d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent ressembler à ceux de la dengue ou de la fièvre de Lassa, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par CCHF ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les piqûres de tiques et porter des vêtements protecteurs lors de l'exposition."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour CCHF ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin commercialement disponible contre CCHF."
}
},
{
"@type": "Question",
"name": "Quelles mesures de contrôle des tiques sont efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des insecticides et maintenir l'environnement propre aide à contrôler les tiques."
}
},
{
"@type": "Question",
"name": "Les animaux domestiques peuvent-ils transmettre CCHF ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les animaux infectés peuvent transmettre le virus aux humains par contact direct."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour les travailleurs de la santé ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent porter des équipements de protection individuelle lors de la prise en charge des patients."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour CCHF ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le soutien symptomatique est essentiel."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre CCHF ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car CCHF est causée par un virus."
}
},
{
"@type": "Question",
"name": "Comment gérer les cas sévères de CCHF ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cas sévères nécessitent une hospitalisation et un traitement de soutien intensif."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour CCHF ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme des anticorps monoclonaux, sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé pour les patients atteints de CCHF ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est crucial pour aider le corps à combattre l'infection."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de CCHF ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le choc, l'insuffisance rénale et les hémorragies sévères."
}
},
{
"@type": "Question",
"name": "CCHF peut-elle entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des séquelles neurologiques ou psychologiques."
}
},
{
"@type": "Question",
"name": "Quel est le taux de mortalité associé à CCHF ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de mortalité varie de 10 à 40 % selon les épidémies et les soins reçus."
}
},
{
"@type": "Question",
"name": "Les complications surviennent-elles rapidement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent survenir dans les jours suivant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "Comment les complications de CCHF sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles nécessitent une prise en charge médicale intensive et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter CCHF ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes travaillant avec des animaux ou dans des zones endémiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs dans certaines régions sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des zones où CCHF est endémique courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un risque accru de développer des formes sévères de la maladie."
}
},
{
"@type": "Question",
"name": "Les agriculteurs sont-ils exposés à CCHF ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les agriculteurs sont souvent en contact avec des animaux porteurs de tiques infectées."
}
},
{
"@type": "Question",
"name": "Les personnes en contact avec des sangs d'animaux sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec le sang d'animaux infectés augmente le risque d'infection."
}
}
]
}
]
}
To evaluate the Mental Health and Primary Care Partnership (MaP) pilot program which operated in a metropolitan Melbourne setting in 2020....
Data collection included: surveys, interviews, file audits, and an evaluation of routinely collected data, with MaP consumers, their carers, GPs, Practice Managers and Nurses located in Boroondara, an...
Thirty-five consumers aged between 66 and 101 years old (of whom 63% were female) received support from the MaP program throughout its 12-month operation. Statistically significant improvements in out...
It is hoped that the learnings from the MaP pilot program can be used to guide future program development....
This study evaluated an epilepsy training program for healthcare workers that was designed to improve their knowledge of epilepsy, its treatment, and its psychosocial effects....
This single group, before and after survey was conducted in three regional referral hospitals in Uganda. Healthcare workers participated in a 3-day epilepsy training program and were assessed immediat...
Twenty healthcare workers from each of our three study hospitals (N = 60) participated in the study. The average age of the participants was 39.9 years (SD = 9.6). Female participants constituted 45% ...
The study suggested that our training program was effective in improving the knowledge of health workers about epilepsy and that participants had favorable impressions of the program. Further work is ...
Formal mentoring programs have direct benefits for academic health care institutions, but it is unclear whether program designs use recommended components and whether outcomes are being captured and e...
We completed a literature review using a comprehensive search in SCOPUS and PubMed (1998-2019), a direct solicitation for unpublished programs, and hand-searched key references, while targeting mentor...
Fifty-eight distinct mentoring programs were represented in the data set. The team members clarified specific mentor roles to assist the analysis. The analysis identified mentoring program characteris...
The review found that several mentor program design, implementation, outcome, and evaluation components are poorly aligned with recommendations, and content for URM and women faculty members is underr...
To describe the reach, implementation, and sustainability of COVID-19 vaccination programs delivered by social service community organizations. Five academic institutions in the Chicagoland CEAL (Comm...
The recent COVID-19 pandemic has led many countries to adopt emergency cash transfer policies as a way to contain the economic and humanitarian crisis. Such initiatives were developed in a context of ...
The Happy Child Program (Programa Criança Feliz - PCF, in Portuguese) reaches 1.4 million Brazilian children under three years of age with home visits aimed at promoting neuropsychomotor development. ...
To determine the contexts under which a fresh food market program is cost-effective in improving dignified access to nutritious food for food-insecure individuals....
A realist economic evaluation was employed. Purported cost related theories about how the program may function, known as context-mechanism-outcome configurations were developed. In-depth interviews wi...
Food insecure individuals attending a partnership fresh food market with a small fee, experienced improved, yet infrequent access to nutritious food through community connections and support a more di...
Food relief should consider alternative models....
More dignified food relief programs that support local connections may be part of the solution to addressing food insecurity....
Beginning in 2010, the U.S. Department of Health and Human Services (HHS) sponsored numerous studies testing the effectiveness of Adolescent Pregnancy Prevention programs on youths' risky sexual behav...
This study aims to evaluate the implementation and describe the actions developed in the School Health Program (PSE) by primary care health teams that joined the Brazilian National Program for Improve...
Burnout and attrition in nursing have been accelerated by the coronavirus disease 2019 (COVID-19) pandemic. Nursing students experience greater stress than non-nursing students but often lack adequate...
This study used qualitative exploratory analysis of support group reflections from 47 graduate nursing students....
Four themes emerged: (1) Making Positive Connections; (2) Leveraging Skills to Manage Stress; (3) Beneficial; and (4) Facing Trauma....
Graduate student-led support groups are a feasible and effective strategy to mitigate stress and improve nursing student resiliency....